Clinical Trials
🇪🇺 EMA Page 11EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 121–132 of 139 articles
BriaCell Bria-OTS+ Shows Preserved Quality of Life in Phase 3 Metastatic Breast Cancer Trial at AACR 2026
Implantica RefluxStop Device Shows Excellent Long-Term Safety in Landmark 602-Patient European Study
AskBio's Ametefgene Parvec Enters Phase II Trial for Parkinson's Disease Gene Therapy
European Academic Clinical Trials: Funding and Success Rates Analysis 2024-2026
Adagene's Muzastotug Shows 66.7% Response Rate in Triple Combination Therapy for Hepatocellular Carcinoma at AACR 2026
Sanofi's Nuvaxovid COVID-19 Vaccine Shows Superior Tolerability Over mNEXSPIKE in Phase 4 Study
AIM ImmunoTech Advances Ampligen to Phase 3 Pancreatic Cancer Trial with Orphan Drug Status
AB Science Secures €25 Million Clinical Trial Insurance for Masitinib ALS Phase III Study
Traws Pharma Advances Tivoxavir Marboxil to Human Influenza Challenge Trial, Reports Positive Ratutrelvir COVID Data
Boehringer Ingelheim and Zai Lab Launch Phase Ib/II Trial for DLL3-Targeting Combination Therapy in Small Cell Lung Cancer
Medicenna's Bizaxofusp Shows Promise in Brain Cancer Trials Ahead of 2026 Investor Conference
Vitestro's Autonomous Robotic Phlebotomy Device Shows Promising Results in Multicenter Clinical Trial